Menu
Česky English
532 23 1111
Česky English
Areál Bohunice
Dětská nemocnice
Porodnice
Úvodní stránka

Příspěvky na mezinárodních konferencích v roce 2003

Ludwig H., Spicka I., Klener P., Greil R., Adam Z, Gisslinger H., Tar-Kovacs G., Linkesch W., Maniatis A., Morant R., Schüller J., Niessner H., Preis P., Drach J., Schuster J.: Randomized Comparison Between VMCP/IFN With Continuous Prednisolone and Conventional VMCP/IFN as First-Line Chemotherapy in Multiple Myeloma. P 228.IXth International Workshop on Multiple Myeloma. 23-27. May 2003.......

  1. Ludwig H., Spicka I., Klener P., Greil R., Adam Z, Gisslinger H., Tar-Kovacs G., Linkesch W., Maniatis A., Morant R., Schüller J., Niessner H., Preis P., Drach J., Schuster J.: Randomized Comparison Between VMCP/IFN With Continuous Prednisolone and Conventional VMCP/IFN as First-Line Chemotherapy in Multiple Myeloma. P 228.IXth International Workshop on Multiple Myeloma. 23-27. May 2003.

  2. Ludwig H., Spicka I., Klener P., Greil R., Adam Z, Gisslinger H., Tar-Kovacs G., Linkesch W., Maniatis A., Morant R., Schüller J., Niessner H., Preis P., Drach J., Schuster J.: Prospective randomized comparison of VMCP-continuous prednisolone and IFN with VMCP-standard prednisolome and IFN in elderly patients with newly diagnosed multiple myeloma.Onkoloie, 26/S5/2003, Abstract P711.

  3. Hajek R., Scudla V., Krejci M., Bacovsky J., Schützova M., Koza V., Tothova E., Papajik T., Frankova H., Stavarová Y., Lehanka F., Vranová M., Kessler P., Pozdenová V., Walterová L., Stefánek I., Novosadová L., Vytrasová M., Meluzínová I., Hausdorf P., Seifertová N., Summa E., Dusek L., Svobodník A., Vorlíček J. , Adam Z., Interim Analysis of Randomized Trial “4W” of Czech Myeloma Group: Maintenance Therapy Interferon Alpha or Sequential Maintenance Therapy Interferon Alpha and Dexametazonea after High-Dose Chemotherapy and Peripheral Blood Stem Cell Transplantation in Newly Diagnosed Patients with Multiple Maeloma. P 230. IXth International Workshop on Multiple Myeloma. Salamanca, Spain. 23-27. May 2003.

  4. Krejči M., Křivanová A., Hájek R., Scudla V., Indrák K., Bačovský J., Büchler T., Pour L., Svobodník A., Adam Z., Mayer J., Vorlíček J.: T2 Model – a Pilot Study for the Evaluation of the Experimental Therapy of Multiple Myeloma Relapsing after the first Autologous stem cell Transplantation. 44Report of the Prospective non-randomized Pilot study of the Czech Myeloma Group. P293. IXth International Workshop on Multiple Myeloma. Salamnca, Spain. 23-27. May 2003.

  5. Doubek M., Mayer J., Koristek Z., Krejci M., Brychtova Y., Navratil M., Vasova I., Tomiska M., Buchtova I., : Allogeneic Hematopoietic Stem Cell Transplantation After a Nonmyeloablative Regimen Containing Fludarabine, Busulfan, and ATG. Single Center Experience. The Hematology Journal Vol.4-Supplement 2 – June 2003. 0208

  6. Doubek M., Mayer J., Krejci M., Oborilova A., Brychtova Y., Buchtova I.,: Pulse Cyclophosphamide (CP) in the Treatment of Steroid – Refractory GCHD. The Hematology Journal Vol.4-Supplement 2 – June 2003. 0209.

  7. Brychtova Y., Doubek M., Pacholikova J., Freiberger T., Krejci M., Horky O., Mayer J., :Dynamics of Minimal Residual Disease and Chimerism After Nonmyeloablative and Myeloablative Stem Cell Transplantations for Chronic Myeloid Leukemia. The Hematology Journal Vol.4-Supplement 2 –June 2003. 0233

  8. Vasova I., Koristek Z., Navratil M., Mayer J., Klabusay M., Kral Z., Cernova T., Oborilova A., Salek D.,: Diffuse large B-Cell Lymphoma (DLBCL) in Patients>60 Years of age. Retrospective one Institution Results of Chop-21 Regimen. Is Intensification of the Treatment Necessary? 8th Annual Congress of the European Hamatologfy Associattion – Lyon, France, 12.15 June 2003. 0323

  9. Crawley C., Szydlo R., Lalanacette M., Bacigalupo A., Lange A., Juliusson G., Shimoni A., Nagler A., Gratwohl A., Mayer J., Ringden O., Boiron J-M, Smith G., Niederwiesse D., Apperley J. for the Chronic Leukaemia Working Party of the EBMT. Sibling and unrelated reduced-intensity conditioned allogeneic transplantation for chronic myeloid leukemia. 29th Annual Meeting of the European Group for Bloo and Marrow Transplantation 19th Meeting of the EBMT Nurses Group 2nd Meeting of the EBMT Data Management Group, Istanbul, Turkey,Volume 31, Supplement 1, Bone Marrow Transplantion, 2003. 0370.

  10. Kubesova B., Stara D., Slavickova E., Mayer J., Krejci M.:Anti-D antibody after Peripheral Blood stem Cell Allograft. Abstract Book. Istanbul-Turkiye, July 5.-9.2003, P 180./

  11. Hajek R., Krivanova A., Krejci M., Scudla V., Bacovsky J., Vytrasova M., Büchler T., Pour L., Vostrejsova S., Koristek Z., Adam Z., Mayer J., Vorlicek J.: Autologous retransplantion in multiple myeloma patients: evaluation of engraftment, toxicity of myeloablative regimen and event-free survival in intra-individual analysis (T2 model). 29th Annual Meeting of the European Group for Bloo and Marrow Transplantation 19th Meeting of the EBMT Nurses Group 2nd Meeting of the EBMT Data Management Group, Istanbul, Turkey, Volume 31, Supplement 1, Bone Marrow Transplantion, 2003. P433

  12. Faitova J., Dvorakova D., Mayer J., Hampl A., Dvorak P.:Accumulation of Fgf-2 in CD34+ cells from chronic myeloid leukemia patients: relationship with malignant phenotype. 29th Annual Meeting of the European Group for Bloo and Marrow Transplantation 19th Meeting of the EBMT Nurses Group 2nd Meeting of the EBMT Data Management Group, Istanbul, Turkey, Volume 31, Supplement 1, Bone Marrow Transplantion, 2003. P483

  13. Elbl L., Krejci M., Mayer J., Koristek Z.: Cyclosporine-induced hypertension and hyperlipidemia after allogeneic peripheral blood stem cell transplantation. 29th Annual Meeting of the European Group for Bloo and Marrow Transplantation 19th Meeting of the EBMT Nurses Group 2nd Meeting of the EBMT Data Management Group, Istanbul, Turkey, Volume 31, Supplement 1, Bone Marrow Transplantion, 2003 . P503

  14. Mayer J., Oborilova A., Krejci M., Doubek M., Bychtova Y.: Pulse cyclophosphamide in the treatment of steroid-refractory GVHD. 19th Meeting of the EBMT Nurses Group 2nd Meeting of the EBMT Data Management Group, Istanbul, Turkey, Volume 31, Supplement 1, Bone Marrow Transplantion, 2003. P534

  15. Mayer J., Doubek M., Koristek Z., Krejci M., Brychtova Y, Navratil M., Vasova I., Tomiska M., Buchtova I.: Allogeneic PBSC transplantation after a non-myeloablative regimen containing fludarabine, busulfan, and ATG: low TRM and good anti-tumor activity. 19th Meeting of the EBMT Nurses Group 2nd Meeting of the EBMT Data Management Group, Istanbul, Turkey, Volume 31, Supplement 1, Bone Marrow Transplantion, 2003. P585

  16. Klabusay M., Koristek Z., Adler J., Mayer J., Vorlicek J.: Isolation, cultivation, and expansion of hematopoietic stem cells ex vivo – finding an optimal cytokine combination. 19th Meeting of the EBMT Nurses Group 2nd Meeting of the EBMT Data Management Group, Istanbul, Turkey, Volume 31, Supplement 1, Bone Marrow Transplantion, 2003. P718

  17. Dvorakova D., Mayer J., Doubek M., Faitova J., Pacholikova J., Hampl A., Dvorak P.: Over-expression of fibroblast growth factor receptor 3 in CD34+BCR-ABL+ cells from patients with chronic myeloid leukemia. 19th Meeting of the EBMT Nurses Group 2nd Meeting of the EBMT Data Management Group, Istanbul, Turkey, Volume 31, Supplement 1, Bone Marrow Transplantion, 2003. P809

  18. Klabusay M., Lysak D., Kovarova L., Koristek Z., Mayer J.: Phenotype af CD34+ stem cell subpopulations in peripheral blood of patients undergoing mobilization of PBSC with cyclophosphamide, etoposide and SC-70935 or G-CSF. P830

  19. Smardova L., Král Z., Cernová T., Vorlicek J.: Incidence of Hodgkins´s lymfoma in the lung, an infrequent case of pulmonary infiltration without mediastinal lymfadenopathy. 8th Congress of the European Hematology Association, Lyon, Francie. 2003.

  20. Pour L., Hájek R., Kamelander J., Krejčí M., Křivanová A., Büchler T, Mayer J., Vorlíček J., Adam Z.: Thalidomid v léčbě mnohočetného myelomu. III.Košické hematologické a transfuziologické dni. 2003, 40.

  21. Hájek R. Křivanová A., Krejčí M., Adam Z., Ščudla V., Bačovský J., Vytřasová M., Pour L., Kamelander J., Svobodník A., Mayer J., Vorlíček J.: Přínos opakované autologní transplantece u nemocných s mnohočetným myelomem. III.Košické hematologické a transfuziologické dni. 2003, 41.

  22. Hájek R., Tóthová E., Mistrík M., Gregora E., Maisnar V., Schützová M., Špička I., Fáber E., Adam Z., Ščudla V.: Multicentrická randomizovaná studie České myelomové skupiny s využitím myeloablativní léčby s podporou autologních periferních kmenových buněk. III.Košické hematologické a transfuziologické dni. 2003, 39.

  23. Racil Z., Skapova D., Minarikova D., Mayer J., Dvorakova D.: Role of reactivation of herpesviruses (CMV, HHV – 6, HSV – 1, HSV – 2) in hemato-oncological patients with high risk of febrile neutropenia. 8. th Congress of the European Hematology Asociation, Lyon, France, 2003.

  24. Ráčil Z., Škapová D., Minaříková D., Dvořáková D., Mayer J.: Reactivation of CMV, HHV-6, HSV-1, HSV-2 in Hematooncological Patients after Intensive Chemotherapy. 6. International Symposium on Febrile Neutropenia, Brussels, Belgium, 2003

  25. Ráčil Z., Tomíška M., Mayer J., Vorlíček J.: Successful Treatment of Invasive Hematooncological Patients. 6. International Symposium on Febrile Neutropenia, Brussels, Belgium, 2003

  26. Kolarova M., Drevova J., Hanulakova D., Racil Z., Mayer J.: Airborne fungal spore monitoring in the oncohematology unit: a 1-year prospective study. 4. Congress of the International Federation of Infection Control (IFIC), Malta, 2003.

  27. Račil Z., Škapová D., Minaříková D., Dvořáková D., Sučíková J., Mayer J.: Reactivation of Herpesviruses (CMV, HHV-6, HSV-1, HSV-2) in Hematooncological Patients after Intensive Chemotherapy. 45. ASH meeting, San Diego, California, USA, 2003, Blood, vol. 102,11, Abstract 5501

  28. Ráčil Z., Mayer J.: Successful Treatment of Resistant Invasive Aspergillosis with Combination of Caspofungin Acetate and Voriconazole during Aggresive Treatment of AML including BMT. 45. ASH meeting, San Diego, California, USA, 2003, Blood, vol. 102,11, Abstract 5499

  29. Klabusay M., Koristek Z., Mayer J., Adler J., Vorlicek J.: All Combinations of Cytokines Stem Cell Factor, Flt-3 Ligand, Interleukin-3, Interleukin-6 and Thrombopoietin Compared in ex Vivo Expansion of Lin Enriched Hematopoietic Stem Cells. Blood, volume 102, 11, 2003. Abstract 5415

  30. Klabusay M., Coupek P., Koristek Z., Mayer J.:The Dose of CD34+36+ Cells Can Predict Time to Engraftment after Allogeneic Matched Related Donor Transplantation Where the dose of CD34+ Cells Fail. Blood , Volume 102.11, Abstract 1705.

  31. Skotnicki A., Robak T., Mayer J., Craig A.: Phase III Study To Evaluate the Efficacy and Safety of Front-Line Therapy with Aletzumab (CAMPATH®, MABCAMPATH®) vs. Chlorambucil in Patients with Progressive B-Cell Chronic Lymphocytic Leukemia (CAM307). Blood, vol 102,11. 2003. Abstract 1599

  32. Račil Z., Škapová D., Minaříková D., Dvořáková D., Sučíková J., Mayer J.: Reactivation of Herpesviruses (CMV, HHV-6, HSV-1, HSV-2) in Hematooncological Patients with risk of febrile neutropenia. 8 EHA Meeting, Lyon 2003

  33. Škapová D., Ráčil Z., Sučiková J., Minarikova D., Dvorákova D., Mayer J.: PCR detection of herpesviruses (CMV, HHV-6, HSV-1, and HSV-2) in peripheral blood of hemato-oncological úatients with high risk of herpesvirus reaction. 6th Annual Meeting of the European Society for Clinical Virology (ESCV), Lyon, France, 2003

  34. Doubek M., Brychtova Y., Mayer J.: Autosomal Dominant Familial Polycythemia with Elevated Serum Erythopoetin. Blood vol. 102/11.2003. Abstract 3758

  35. Pacholikova J., Brychtova Y., Doubek M., Mentzlova D., Dvorakova D., Mayer J.:Molecular Methods To Assess Imatinib Responses in CML Patients. Blood vol. 102/11. Abstract 4593

  36. Doubek M., Tomiska M., Koristek Z., Brychtova Y., Mayer J.: Systemic Cappillary Leak Syndrome Misdiagnosed as Polycythemia Vera. Blood vol. 102/11. 2003. Abstract 5067

  37. Mayer J., Doubek M., Brychtova Y, Krejci M.: Pulse Cyclophosphamide (CP) in the Treatment of Steroid-Refractory GvHD. Blood vol. 102/11. 2003. Abstract 5516

  38. Racil Z., Mayer J.: Successful Treatment of Resistant Invasive Aspergillosis with Combination of Caspofungin Acetate and Voriconazole during Aggresive Treatment of AML including BMT. Blood vol. 102/11. 2003. Abstract 5499

  39. Racil Z., Skapova D., Minarikova D., Dvorakova D., Sucikova J., Mayer J.: Reactivation of Herpesviruses (CMV, HHV-6, HSV-1, HSV-2) in Hematooncological Patients after Intensive Chemoterapy. Blood vol. 102/11. 2003. Abstract 5501

  40. Oborilova A., Mayer J., Dvorakova D., Cernova T., Vasova M., Navratil M.: Molecular monitoring t (14.,18) and correlation between clinical and molecular response in follicular lymphoma after chemotherapy. The Hematology Journal 2003, 4 (Suppl 2):96

  41. Sláma O., Beránek M., Haklová O., Vorlíček J.,: Suryey of cancer pain issues among czech oncologist. 4th Congress of EFIC, Praha , Poster No 836

  42. Fojtík Z., Kořístek Z.: .: Recidivující trombotická trombocytopenická purpura u nemocné se SLE. VII.Siťajov reumatol. Seminár,12-13,12,2003, Piešťany.

  43. Fojtík Z., Beránek M., Klabusay M., Kořístek Z.: Význam screeningových koagulačních testů pro diagnostiku lupus antikoagulant. 47.zjazd slovenských a českých reumatologov. 1-4,10,2003. Košice.

  44. Pacholikova J., Brychtova Y, Doubek M., Mentzlova D., Dvorakova D., Mayer J.: Molecular Methods to Asses Imatinib Responses in CML Patients. 45th Annual Meeting and Exposition of American society of Hematology. 6.-9.12. San Diego

  45. Fajkusova L., Vojtová J.: Role of alternative spilicing in the human dystrophin gene. XIX. International Congress of Genetics, Book of Abstracts p. 78, 6-11. July 2003, Melbourne, Australia

  46. Bzdúch V., Behulová D., Kozák L.,: Smith-Lemli-Opitz syndrome – the best-studied model of genetically determined disorders. Problémy klinické genetiky, Charkov, Ukrajina září 2003.

  47. Klabusay M., Kořístek Z., Vinklárková L., Mayer J., Adler J: Isolation, cultivation, and expansion of hematopoietic stem cells ex vivo: which cytokines should be used? 12th international congress of the European association of tissue banking, Brugge, Belgium, 2003, lecture

  48. Klabusay M. Kořístek Z., Vinklárková J., Adler J., Mayer J.: Izolace, kultivace a expanze hematopoetických kmenových buněk ex vivo. XVII.Olomoucké hematologické dny, Olomouc 2003.

FN Brno je státní příspěvková organizace zřízená rozhodnutím Ministerstva zdravotnictví. Nemá zákonnou povinnost zápisu do obchodního rejstříku, je zapsána do živnostenského rejstříku vedeného Živnostenským úřadem města Brna.

Fakultní nemocnice Brno - snadné čtení (dle metodiky „Easy to read“) Srozumitelné informace

Bohunice Dětská nemocnice Porodnice

Jihlavská 20, Brno
Telefon: 532 23 1111
E-mail:

Nastavení soukromí

© Fakultní nemocnice Brno. Všechna práva vyhrazena. | developed by Via Aurea s.r.o.

Informace o pohotovosti v Brně a Jihomoravském kraji